199 related articles for article (PubMed ID: 26511074)
1. Coagulation activation in sickle cell trait: an exploratory study.
Amin C; Adam S; Mooberry MJ; Kutlar A; Kutlar F; Esserman D; Brittain JE; Ataga KI; Chang JY; Wolberg AS; Key NS
Br J Haematol; 2015 Nov; 171(4):638-46. PubMed ID: 26511074
[TBL] [Abstract][Full Text] [Related]
2. Thromboelastographic characterization of the activated clotting system in children with sickle cell trait or sickle cell disease.
Gupta S; Carmona R; Malvar J; Young G
Thromb Res; 2017 Mar; 151():44-50. PubMed ID: 28110132
[TBL] [Abstract][Full Text] [Related]
3. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
[TBL] [Abstract][Full Text] [Related]
4. Procoagulant activity in patients with sickle cell trait.
Lawrie AS; Pizzey A; Trompeter S; Meiselman H; Mohandas N; Dumanski JP; Westerman MP
Blood Coagul Fibrinolysis; 2012 Jun; 23(4):268-70. PubMed ID: 22343687
[TBL] [Abstract][Full Text] [Related]
5. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.
Kurantsin-Mills J; Ofosu FA; Safa TK; Siegel RS; Lessin LS
Br J Haematol; 1992 Aug; 81(4):539-44. PubMed ID: 1390242
[TBL] [Abstract][Full Text] [Related]
6. Coagulation changes in individuals with sickle cell trait.
Westerman MP; Green D; Gilman-Sachs A; Beaman K; Freels S; Boggio L; Allen S; Schlegel R; Williamson P
Am J Hematol; 2002 Feb; 69(2):89-94. PubMed ID: 11835343
[TBL] [Abstract][Full Text] [Related]
7. Thrombophilia in sickle cell disease: the red cell connection.
Setty BN; Rao AK; Stuart MJ
Blood; 2001 Dec; 98(12):3228-33. PubMed ID: 11719358
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor-positive monocytes in children with sickle cell disease: correlation with biomarkers of haemolysis.
Setty BN; Key NS; Rao AK; Gayen-Betal S; Krishnan S; Dampier CD; Stuart MJ
Br J Haematol; 2012 May; 157(3):370-80. PubMed ID: 22360627
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide-prednisone maintenance following autologous stem cell transplant for multiple myeloma: effect on thrombin generation and procoagulant markers in NCIC CTG MY.10.
Kovacs MJ; Davies GA; Chapman JA; Bahlis N; Voralia M; Roy J; Kouroukis CT; Chen C; Belch A; Reece D; Zhu L; Meyer RM; Shepherd L; Stewart KA
Br J Haematol; 2015 Feb; 168(4):511-7. PubMed ID: 25302852
[TBL] [Abstract][Full Text] [Related]
10. Relationship between coagulation cascade, cytokine, adhesion molecule and aortic aneurysm.
Nomura F; Ihara A; Yoshitatsu M; Tamura K; Katayama A; Ihara K
Eur J Cardiothorac Surg; 2003 Jun; 23(6):1034-8; discussion 1038-9. PubMed ID: 12829084
[TBL] [Abstract][Full Text] [Related]
11. Oxygen delivery index in subjects with normal haemoglobin (HbAA), sickle cell trait (HbAS) and homozygous sickle cell disease (HbSS).
Bowers AS; Pepple DJ; Reid HL
Clin Hemorheol Microcirc; 2008; 40(4):303-9. PubMed ID: 19126993
[TBL] [Abstract][Full Text] [Related]
12. Optimal haematocrit in subjects with normal haemoglobin genotype (HbAA), sickle cell trait (HbAS), and homozygous sickle cell disease (HbSS).
Bowers AS; Pepple DJ; Reid HL
Clin Hemorheol Microcirc; 2011; 47(4):253-60. PubMed ID: 21654054
[TBL] [Abstract][Full Text] [Related]
13. Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.
Hyacinth HI; Adams RJ; Greenberg CS; Voeks JH; Hill A; Hibbert JM; Gee BE
PLoS One; 2015; 10(8):e0134193. PubMed ID: 26305570
[TBL] [Abstract][Full Text] [Related]
14. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty.
Tschopl M; Tsakiris DA; Marbet GA; Labs KH; Jäger K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3208-14. PubMed ID: 9409313
[TBL] [Abstract][Full Text] [Related]
15. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
Bremme K; Lind H; Blombäck M
Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
White D; MacDonald S; Edwards T; Bridgeman C; Hayman M; Sharp M; Cox-Morton S; Duff E; Mahajan S; Moore C; Kirk M; Williams R; Besser M; Thomas W
Int J Lab Hematol; 2021 Feb; 43(1):123-130. PubMed ID: 32892505
[TBL] [Abstract][Full Text] [Related]
17. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
[TBL] [Abstract][Full Text] [Related]
18. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation.
Gando S; Nanzaki S; Sasaki S; Kemmotsu O
Thromb Haemost; 1998 Jun; 79(6):1111-5. PubMed ID: 9657433
[TBL] [Abstract][Full Text] [Related]
19. [Hemostasis alterations in sickle cell syndrome].
Higuera D; Bravo M; Guerrero B
Invest Clin; 2014 Jun; 55(2):173-84. PubMed ID: 24974633
[TBL] [Abstract][Full Text] [Related]
20. Sickle cell trait and the risk of venous thromboembolism among blacks.
Austin H; Key NS; Benson JM; Lally C; Dowling NF; Whitsett C; Hooper WC
Blood; 2007 Aug; 110(3):908-12. PubMed ID: 17409269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
